August 19th, 2012
Introducing
The Rowboat
Quite Possibly The Holy Grail of Investing.
Step 1
: Sell the Put
( This is a Cash Covered Put, I have to have enough Cash to cover if the option is
exercised, this is a
lso my maximum risk.)
QCOR
@ $39.59
Questcor Pharmaceuticals, Inc. (QCOR)
Sell to open QCOR Sep12 35 Put @ market
Currently .95c bid / .98c time value
2.71%
return in 27 day
How to do this trade Video:
(Sign up for Auto

trading and have this trade
done for you automatically)
http://youtu.be/jOBnvUq-L1A

Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription
drugs for the treatment of multiple sclerosis, nephrotic syndrome, a
nd infantile spasms
indications. It primarily offers H.P. Acthar Gel, an injectable drug for the treatment of
acute exacerbations of multiple sclerosis in adults; to induce a diuresis or a remission of
proteinuria in the nephrotic syndrome without uremia o
f the idiopathic type or that due to
lupus erythematosus; and as monotherapy for the treatment of infantile spasms in
infants and children under two years of age. The company H.P. Acthar Gel also
focuses on rheumatology

related conditions, including coll
agen diseases and rheumatic
disorders. In addition, it offers Doral for the treatment of insomnia. The company sells its
Acthar primarily to specialty pharmacies; and Doral to pharmaceutical wholesalers.
Questcor Pharmaceuticals, Inc. was founded in 1990 a
nd is headquartered in Anaheim,
California.
Questcor Pharmaceuticals, Inc.
1300 North Kellogg Drive
Suite D
Anaheim, CA 92807
Phone: 714

786

4200
Fax: 714

789

4229
Website:
http://www.questcor.com
Remember,
no more than 5 or 10% of your portfolio should ever go
into any one trade or position Step 2:
IF
it got Put to us,
Now we “Lock

in” a profit.
Sell
the
Covered Call
(Do not buy this stock just to sell the covered Call)
ELN
@ $11.72
Sell To Open
ELN October 2012 13 Call @ Market
currently @ .35c bid / .40c ti
me
How to do this trade Video:
(Sign up for Auto

trading and have this trade done for you automatically)
http://youtu.be/BtN9bIRddVk
History:
Cost basis
$12.00
per share.
Premiums collected:
1.20c
per share
10%
Return in 1 months
$10,000 would have generated
$1000.00
actual trades:
07/23/2012 Sell To Open
ELN Aug12 12 Put $1.20
10%
return in 27 days
Elan Corporation, plc operates as a neuroscience

based biotechnology company in the
United States, Irel
and, and internationally. It engages in research, development, and
commercial activities primarily in the areas of Alzheimer disease, and multiple sclerosis (MS). The company offers Tysabri, an alpha

4 integrin
inhibitor primarily fo
r the treatment of MS. It is also developing ELND005, a beta amyloid
anti

aggregation agent to treat Alzheimerdisease, which completed Phase II clinical
trial. In addition, the company focuses on the discovery and development of antibodies
to neo

epitop
e related targets for the treatment of a range of indications, including
amyloidosis, diabetes, cancer, and macular degeneration; and drugs for oncology
related diseases comprising NEOD001 for the treatment of AL amyloidosis, as well as focuses on developi
ng ELND005 for bipolar disorder. Further, the company, through
collaboration agreement with Biogen Idec, Inc., develops and markets Tysabri for the
treatment for Crohndisease. Additionally, Elan Corporation, plc, through a 49.9%
interest in Janssen AI,
develops beta amyloid immunotherapies, including
bapineuzumab, ACC

001, and other compounds to treat Alzheimerisease.
The company also has collaboration agreements with Cambridge

Elan Centre, Dublin
Neurological Institute, University College Dublin,
and Proteostasis. Elan Corporation, plc
was founded in 1969 and is headquartered in Dublin, Ireland.
Elan Corporation, plc
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland
Phone: 353 1 709 4000
Fax: 353 1 709 4700
Website:
http://www.elan.com
Remember, no more than 5 or 10% of your portfolio should ever go
into any one trade or position How did we do last Month? / Current/Older
Positions/History
This includes a running total for each position.
AMRN
@ $11.88
Amarin Corporation plc (AMRN)
Put expired as planned locking in a
profit of 5%
Hist
ory:
Cost basis
$10.00
per share.
Premiums collected:
.50c
per share
5%
Return in 1 months
$10,000 would have generated
$500.00
actual trades:
07/23/2012 Sell To Open
AMRN Aug12 10 Put $0.50
5%
return in 27 days
Amarin Corporation plc, a late

s
tage biopharmaceutical company, focuses on developing
the treatment for cardiovascular disease in the field of lipid science. Its lead product
candidate includes AMR101, a prescription

only omega

3 fatty acid comprising
icosapent ethyl, or ethyl

EPA for th
e treatment of patients with very high triglyceride
levels and high triglyceride levels or hypertriglyceridemia. The company, formerly know

as Ethical Holdings plc, was founded in 1989 and is headquartered in Dublin, Ireland.
Amarin Corporation plc
Firs
t Floor, Block 3
The Oval
Dublin, 4
Ireland

Phone: 353 1 669 9020
Fax: 353 1 669 9028
Website:
http://www.amarincorp.com
CLWR
@ $1.82
Hold:
Jan13 $5 Call still cooking
History:
Cost basis
$3.00
per shar
e.
Premiums collected:
.85c
per share
28.33%
Return in 12 months
$10,000 would have generated $2833.00
actual trades:
06/18/2012 Sell To Open
CLWR Jan13 5 Call $0.05
09/19/2011 Sell To Open
CLWR Jan12 4 Call $0.30
09/16/2011 Buy To Close
CLWR Sep11 3 Pu
t
09/16/2011 Buy CLWR

Option Assignment
$3.00
08/23/2011 Sell To Open
CLWR Sep11 3 Put $0.50
Clearwire Corporation, through its subsidiaries, provides fourth generation
wireless broadband services in the United States. The company builds and
operates m
obile broadband networks that offer high

speed mobile Internet
and residential Internet access services. It serves retail customers through its
CLEAR brand. The company markets its products and services directly to
consumers, as well as through cellular re
tailers, consumer electronics stores,
satellite television dealers, and computer sales and repair stores; and through
company

operated retail outlets. As of December 31, 2011, it had
approximately 1.3 million retail and 9.1 million wholesale subscribers. T
he
company is headquartered in Bellevue, Washington. Clearwire Corporation is
a subsidiary of Sprint HoldCo LLC.
DMND
@ $18.35
Put to us @ $32.00
Hold
There are no good bids on the $33.00 call at this time.
This stock could gap up significantly on t
he upcoming earnings report.
History:Cost basis
$32.00
per share.
Premiums collected:
1.95
per share
6%
Return in 6 months
$10,000 would have generated
$600.00
actual trades:
03/20/2012 Sell To Open DMND Jun12 33 Call $0.25
03/18/2012 Buy To Close
EXPIRED DMND Mar12 32 CALL
02/21/2012 Sell To Open DMND Mar12 32 Call $0.20
02/17/2012 Buy DMND

Option Assignment $32.00
02/17/2012 Buy To Close
DMND Feb12 32 Put
02/06/2012 Sell To Open DMND Feb12 32 Put $1.50
Diamond Foods, Inc. engages in proces
sing, marketing, and distributing snack
products. It provides snack products, including roasted, glazed and flavored nuts, trail
mixes, dried fruit, seeds, microwave popcorn products, and potato and tortilla chips
under the Emerald, Pop Secret, and Kettle
brands. The company also offers culinary,
in

shell, and ingredient nuts under the Diamond of California brand name. It markets
its culinary nuts to individuals who prepare meals or baked goods at home; and
ingredient nuts to food processors, restaurants, b
akeries, and food service companies
and their suppliers. The company sells its products directly to national grocery, mass
merchandiser, clubs, convenience stores, and drug store chains in the United States,
the United Kingdom, Germany, the Netherlands, Sp
ain, Canada, South Korea, Turkey,
China, and Japan. Diamond Foods, Inc. was founded in 1912 and is based in San
Francisco, California.
Diamond Foods, Inc.
600 Montgomery Street
13th Floor
San Francisco, CA 94111

2702
Phone: 415

445

7444
Website:
http://www.diamondfoods.com
FMCN
@ $25.22
Focus Media Holding Ltd
Hold
There is a bid to buy this company @ $27 per share
I have seen valuations of up to $38.00 per share, it would be prudent
to let
this one cook for a while.
History:Cost basis $
24.00
per share.
Premiums collected:
$ 1.50
per share
6.25
% Return in 5 months
$10,000 would have generated $625.00
08/14/2012 Buy To Close
FMCN Oct12 27 Call

$0.50
07/23/2012 Sell To Open
F
MCN Oct12 27 Call $0.40
05/21/2012 Sell To Open
FMCN Jul12 27 Call$0.40
04/23/2012 Sell To Open
FMCN May12 27 Call $0.45
04/20/2012 Buy FMCN

Option Assignment
$24.00
04/20/2012 Buy To Close
FMCN Apr12 24 Put
03/19/2012 Sell To Open
FMCN Apr12 24 Put $1
.15
Focus Media Holding Limited, a multi

platform digital media company,
operates liquid crystal display (LCD) network using audiovisual digital
displays in China. The company engages in selling out

of

home advertising
time slots on its network of flat

p
anel digital advertising displays located in
high traffic areas of commercial, residential, and public buildings, such as
malls, hotels, and the lobbies of apartment buildings, as well as in

store
network. It provides advertising services on poster frames,
on screens in
movie theatres, and on traditional outdoor billboards. As of December 31,
2011, the company had a LCD display network of approximately 155,751 flat

panel digital displays in approximately 114 cities; in

store network of
approximately 50,076
LCD displays in approximately 1,576 hypermarkets,
217 supermarkets, and 1,008 convenience stores; poster frame network of
approximately 445,126 non

digital frames and LCD 1.0 picture frame
devices, as well as leased screen time in approximately 316 movie t
heaters,
including 2,190 screens. Focus Media Holding Limited is headquartered in
Central, Hong Kong.
GMCR
@ $24.95
(Put to us @ $40.00)
Hold September $41 call is still cooking
History:
Cost basis $
40.00
per share.
Premiums collected:
$ 2.86
p
er share
7.15
% Return in 4 months
$10,000 would have generated $2860.00
05/21/2012 Sell To Open
GMCR Sep12 41 Call $0.72
04/23/2012 Sell To Open
GMCR May12 40 Put $2.14
Green Mountain Coffee Roasters, Inc. engages in the specialty coffee and
coffee ma
ker business. The company sources, produces, and sells
approximately 200 varieties of coffee, cocoa, teas, and other beverages in K

Cup portion packs and coffee in traditional packaging, including whole bean
and ground coffee
selections in bags and ground
coffee in fractional packs for
use in at

home (AH) and away

from

home (AFH). It sells its products
primarily in North America through supermarkets, club stores, and
convenience stores; in restaurants and hospitality; and to office coffee
distributors, as w
ell as directly to consumers through its Website. The
company also manufactures gourmet single

cup brewing systems and brewing
equipment. In addition, it sells AH single

cup brewers; accessories; and
coffee, tea, hot cocoa, and other beverages in K

Cup por
tion packs, as well as
offers other licensed roasters to retailers, department stores, and mass
merchandisers. Further, the company sells AFH single

cup brewers to
distributors for use in offices. It provides its products under the Van Houtte,
Brûlerie St.
Denis, Brûlerie Mont

Royal, and Orient Express brands, as well
as licensed Bigelow and Wolfgang Puck brands. The company was founded in
1981 and is based in Waterbury, Vermont.
Green Mountain Coffee Roasters Inc.
33 Coffee Lane
Waterbury, VT 05676
Phone
: 802

244

5621
Fax: 802

244

5436
Website:
http://www.greenmountaincoffee.com
ONTY
@ $4.60
Hold
November $7.00 Calls, still cooking
History:
Cost basis
$5.00
per share.
Premiums collected:
1.95
per share
39%
Return in 5 months
$10,000 would have generated
$3900.00
actual trades:
05/21/2012 Sell To Open
ONTY Nov12 7 Call $0.05
03/20/2012 Sell To Open ONTY May12 6 Call $0.05
03/1
6/2012 Buy ONTY

Option Assignment
$5.00
03/16/2012 Buy To Close
ONTY Mar12 5 Put
02/21/2012 Sell To Open
ONTY Mar12 5 Put $0.70
02/19/2012 Buy To Close
EXPIRED ONTY FEB12 5 PUT
01/30/2012 Sell To Open
ONTY Feb12 5 Put $0.50
01/22/2012 Buy To Close
EX
PIRED ONTY JAN12 5 PUT
01/09/2012 Sell To Open
ONTY Jan12 5 Put $0.30
Oncothyreon Inc.(ONTY), a clinical

stage biopharmaceutical company, focuses
on the development of therapeutic products for the treatment of cancer. Its
primary product candidate, Stim
uvax is in Phase III clinical trials for the

treatment of non

small cell lung cancer. The company also develops PX

866, a
small molecule that is in Phase II trials. In addition, it engages in the preclinical
development of ONT

10, a cancer vaccine. The com
pany operates in Canada,
the United States, Barbados, and Europe. Oncothyreon Inc. was founded in
1985 and is headquartered in Seattle, Washington.
Oncothyreon Inc
2601 Fourth Avenue
Suite 500
Seattle, WA 98121
Phone: 206

801

2100
Fax: 206

801

2101
Webs
ite:
http://www.oncothyreon.com
PAAS
@ $16.33
Hold
There are no good options at this time
History:
Cost basis
$36.00
per share.
Premiums collected:
$3.45
per share
Dividends : .
07c
Total:
$3.52
9.77%
Return in 15 months
$10,000 would have generated $977.00
actual trades:
01/30/2012Sell To Open1PAAS Jul12 36 Call $0.20
12/06/2011 PAAS

PAAS QUALIFIED DIVIDEND $.025
10/24/2011 Sell To Open
PAAS Jan12 36 Call $0.40
10/22/2011 Buy To Close
EXPIRE
D PAAS Oct11 36 Call
09/08/2011 PAAS

PAAS QUALIFIED DIVIDEND $.025
06/20/2011 Sell To Open
PAAS Oct11 36 Call $0.80
06/19/2011 Buy To Close
EXPIRED PAAS JUN11 36 CALL
06/16/2011 PAAS QUALIFIED DIVIDEND $.025
05/23/2011 Sell To Open
PAAS Jun11 36 Cal
l $0.50
05/20/2011 Buy PAAS

Option Assignment
$36.00
05/20/2011 Buy To Close
PAAS May11 36 Put $0.00
04/18/2011 Sell To Open
PAAS May11 36 Put $1.55
Pan American Silver Corp. engages in the exploration, development, extraction,
processing, productio
n, refining, reclamation, and operation of silver properties. The
company also produces and sells gold, zinc, lead, and copper. As of April 27, 2011, it
had seven silver mining operations in Mexico, Peru, Argentina, and Bolivia. The
company was founded in
1979 and is headquartered in Vancouver, Canada.
Pan American Silver Corp.
625 Howe Street
Suite 1500
Vancouver, BC V6C 2T6

Phone: 604

684

1175
Fax: 604

684

0147
Website:
http://www.panamericansilver.com
PAY
@ $32.95
(Put to us @ $43.00)
HOLD
Oct12 $44 Call
Still cooking
History:
Cost basis
$43.00
per share.
Premiums collected:
$3.26
per share
7.58%
Return in 14 months
$10,000 would have generated
$75
8.00
actual trades:
06/18/2012 Sell To Open PAY Oct12 $44 Call $0.35
05/21/2012 Sell To Open
PAY Jun12 50 Call $1.00
04/16/2012 Sell To Open
PAY May12 57.5 Call $1.02
04/16/2012 Buy To Close
PAY Apr12 49 Call

$5.36
01/23/2012 Sell To Open
PAY Apr12
49 Call $0.40
01/22/2012 Buy To Close
EXPIRED PAY JAN12 49 CALL
10/31/2011 Sell To Open
PAY Jan12 49 Call $0.90
10/31/2011 Buy To Close
PAY Jan12 46 Call

$1.90
10/24/2011 Sell To Open PAY Jan12 46 Call $1.10
10/22/2011 Buy To Close
EXPIRED PAY Oct11
42 Call
08/23/2011 Sell To Open
PAY Oct11 42 Call $0.60
08/21/2011 Buy To Close
EXPIRED PAY AUG11 46
CALL
07/19/2011 Sell To Open
PAY Aug11 46 Call $1.05
07/17/2011 Buy To Close
EXPIRED PAY JUL11 44 CALL
06/20/2011 Sell To Open
PAY Jul11 44 Call $0.75
06
/17/2011 Buy To Close
PAY Jun11 43 Put $0.00
06/17/2011 Buy PAY

Option Assignment $43.00
05/23/2011 Sell To Open
PAY Jun11 43 Put $1.70
VeriFone Systems, Inc. designs, markets, and services electronic payment solutions that
enable secure electronic pay
ments among consumers, merchants, and financial
institutions worldwide. The company provides countertop electronic payment systems
that accept magnetic, smart card, and contactless/radio frequency identification cards;
and support credit, debit, check, ele
ctronic benefits transfer, and various pre

paid
products, as well as offers wireless system solutions. The company also provides
products for the point of sale applications, which include displays, user

friendly
interfaces, electronic cash registers (ECR)
interfaces, durable key pads, and signature
capture functionality; and contactless/near field communication (NFC) payment solutions
for consumer

activated transactions using contactless cards, tokens, or NFC enabled mobile phones. In addition, it offers va
rious products for petroleum companies, such as
integrated electronic payment systems that combine card processing, fuel dispensing,
and ECR functions, as well as secure payment systems for integration with petroleum
pump controllers and systems. Further,
the company provides server

based transaction
products; secure payment hardware and software integration modules; and VeriShield
Protect, a solution that encrypts and protects consumer card data. Additionally, it offers
client services, including payment s
ystem consulting, deployment, on

site and
telephone

based installation and training, help desk support, repairs, replacement of
impaired system solutions, asset tracking, and reporting; and project management
services. The company serves financial institut
ions, payment processors, petroleum
companies, retailers, government organizations, and healthcare companies, as well as
independent sales organizations. The company was formerly known as VeriFone
Holdings, Inc. and changed its name to VeriFone Systems, In
c. in May 2010. The
company is headquartered in San Jose, California.
VeriFone Systems, Inc
2099 Gateway Place
Suite 600
San Jose, CA 95110
Phone: 408

232

7800
Fax: 408

232

7811
Website:
http://www.verifone.com
TPX
@ $33
.52
Hold
Sept12 $41 still cooking
History:
Cost basis
$40.00
per share.
Premiums collected:
$1.00
per share
2.5%
Return in 3 months
$10,000 would have generated $400.00
actual trades:
06/18/2012 Sell To Open TPX Sep12 41 Call $0.05
06/16/2012 Buy
TPX

Option Assignment $40.00
05/21/2012 Sell To Open TPX Jun12 40 Put $0.95
Tempur

Pedic International Inc. engages in the manufacture, marketing, and
distribution of bedding products in North America and internationally. It
offers mattresses, pillows,
and adjustable bed bases, as well as various
cushions and other comfort products. The company sells its products under
the TEMPUR and Tempur

Pedic brand names through furniture and bedding
retailers, and non

spring and department stores; direct response p
rogram,
Internet, and company

owned stores; hospitals, nursing homes, healthcare
professionals, and medical retailers; and third party distributors. Tempur

Pedic International Inc. was founded in 1989 and is headquartered in
Lexington, Kentucky.
Tempur P
edic International Inc.1713 Jaggie Fox Way
Lexington, KY 40511
Phone: 800

878

8889
Fax: 859

514

4422
Website:
http://www.tempurpedic.com
TRGT
@ $4.94
Hold
Take no action
There is no good option in
terest at this time.
History:
Cost basis
$12.50
per share.
Premiums collected:
$2.25
per share
18%
Return in 10 months
$10,000 would have generated $1800.00
actual trades:
02/21/2012 Sell To Open
TRGT May12 15 Call $0.25
11/28/2011 Sell To Open
TRG
T Feb12 15 Call $0.40
11/18/2011 Buy To Close
TRGT Nov11 12.5 Put
11/18/2011 Buy TRGT

Option Assignment $12.50
10/23/2011 Sell to Open TRGT Nov 11 $12.50 PUT $1.60
Targacept, Inc., a biopharmaceutical company, engages in the design,
discovery, and de
velopment of novel Neuronal Nicotinic Receptors (NNR)
Therapeutics for the treatment of diseases and disorders of the nervous
system. Its lead program, TC

5214, a nicotinic channel modulator, is in Phase
3 clinical trials as an adjunct treatment for major
depressive disorder (MDD)
and in Phase 2b clinical trial for switch monotherapy in patients with MDD.
The company s novel small molecule product candidates under Phase 2
clinical development include TC

5619 for treating negative symptoms and
cognitive dysf
unction in schizophrenia, attention deficit/hyperactivity
disorder, and Alzheimer s disease; AZD3480 as a treatment for mild to
moderate Alzheimer s disease; AZD1446 as a treatment for Alzheimer s
disease; and TC

6987 for the treatment of inflammatory diso
rders, including
asthma and Type 2 diabetes. It has a collaborative research and license
agreement with AstraZeneca AB for the development and commercialization
of AZD3480, TC

5214, and TC

5619; and a product development and
commercialization agreement wit
h SmithKline Beecham Corporation to
discover, develop, and market product candidates that selectively target
specified NNR subtypes in specified therapeutic focus areas. The company
was founded in 1997 and is based in Winston

Salem, North Carolina. Targa
cept, Inc.
200 East First Street
Suite 300
Winston

Salem, NC 27101

4165
Phone: 336

480

2100
Fax: 336

480

2107
Website:
http://www.targacept.com
ZNGA
@ $3.00
Hold
Take no action
There is no good option interest at th
is time.
History:
Cost basis
$14.00
per share.
Premiums collected:
$2.05
per share
14.64%
Return in 7 months
$10,000 would have generated
$1464.00
actual trades:
03/19/2012 Sell To Open
ZNGA Apr12 16 Call $0.20
03/18/2012 Buy To Close EXPIRED ZNGA M
AR12 15 CALL
02/21/2012 Sell To Open
ZNGA Mar12 15 Call $0.40
02/17/2012 Buy
ZNGA

Option Assignment $14.00
02/17/2012 Buy To Close
ZNGA Feb12 14 Put
02/06/2012Sell To Open ZNGA Feb12 14 Put$1.55
Zynga Inc. develops, markets, and operates online socia
l games as
live services on the Internet, social networking sites, and mobile
platforms. The company offers its online social games under the
CityVille, Zynga Poker, FarmVille, CastleVille, FrontierVille, Mafia
Wars, Word with Friends, Hidden Chronicles, Z
ynga Bingo, Scramble
With Friends, Slingo, and Dream Heights names. Its games are
available on various platforms, including Facebook and other social
networks, as well as mobile platforms, such as Apple iOS and Google
Android worldwide. The company was for
merly known as Zynga Game
Network Inc. and changed its name to Zynga Inc. in November 2010.
Zynga Inc. was founded in 2007 and is headquartered in San
Francisco, California.
Zynga, Inc.
699 Eighth Street
San Francisco, CA 94103
Phone: 855

449

9642
Fax: 3
02

636

5454
Website:
http://www.zynga.com

Quote of the Month:

You only have to do a very few things right in your life so long
as you don’t do too many things wrong. “
~
Warren Buffet
Until Next Time
Brad Lee
The Options Oracle

Summary:
Sell to open QCOR Sep12 35 Put @
market
Sell To Open ELN Oct 2012 13 Call
@ Market
Greetings and Welcome aboard to all
new subscribers.
Congrats to al
l with successful trades.
Company News
Auto Trading is now active!
Don’t want to be bothered doing the
trades?
Auto

trading is for you. Your account will
automatically do whatever I do.
You are still in control, you set the limits
either a dollar amount
or a percentage.
Go to:
https://theoptionsoracle.com/auto-trading/

Ask The Oracle”
webinar Sunday 8 pm
est
to explain this newsletter, or other
questions you might have.
Here is the
link
http://www.anymeeting.com/MoneyMedic1
Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Licensed
Professional adviser
https://theoptionsoracle.com/auto-trading/
Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Lic
ensed
Professional adviser
Company News
Auto Trading is now active!
Don’t want to be bothered doing the
trades?
Auto

trading is for you. Y
our account
will automatically do whatever I do.
You are still in control, you set the
limits either a dollar amount or a
percentage.
Go to the main site, the Auto

trade
link is on the site
https://theoptionsoracle.com/
We will be doing a w
ebinar
Sunday 8 pm est to explain this
newsletter.
Here is the link
http://www.anymeeting.com/MoneyMedic1
Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Che
ck with your Licensed
Professional adviser
O
ptions involve risk and are not suitable
for all investors. Prior to trading options,
you must be approved for options
trading and read the Characteristics
and Risks of Standardized Options.
Copies of this document may also be
obtained from your broker, f
rom any
exchange on which options are traded, by
placing an order online, or by contacting
the Options Clearing Corporation directly
at 1 N. Wacker Dr., Suite 500, Chicago, IL
60606. (1

888

678

4667).
Brad Lee AKA “The Options Oracle”
and “The Money Me
dic” is an
individual investor who does not
manage money for any financial
institution.You are purchasing the list
of stocks that he uses to select
options contracts he feels will return
him the highest, safest profits. Brad is
not a broker, or financial a
dviser. He
is a remarkable investor who has
developed a successful strategy for
himself, and is willing to share some
of his magic with you. We urge you to
paper trade these picks and learn
how to develop a strategy that is
appropriate for you. Thank You.
We make no recommendations on
investment and we do not provide
financial, tax or legal advice. Content
and tools are provided for educational
and informational purposes only.
Disclaimer
Trading or investment in stocks, futures & options, and commodi
ty are subject to potential
market risks. You can use our materials or
recommendations for educational purposes,
this is not intended as Trading or Investment
advice. We are not financial advisers. We
cannot provide any advice as to whether or not
options
or our trading ideas are suitable
investments for your particular financial
situation. We are in the business of publishing
our trade ideas for market analysis only. We
highly recommend that our subscribers review
their trading allocation with a qualified
registered financial adviser/planner.
Legal Disclaimer: we do not exist to render and
do not give legal, tax, economic or investment
advice and disclaims all liability for the actions
or inaction taken or not as a result of
communications from or to its
members,
officers, directors, employees and contractors.
Each individual should consult his/her own
counsel, accountant and other advisors as to
legal, tax, economic, investment and related
matters concerning any type of investments.
This email and any f
iles transmitted with it are
solely intended for the use of the addressee(s)
and may contain information that is confidential
and privileged. If you receive this email in error,
please advise us by return email immediately.
Please also disregard the conten
ts of the email,
delete it and destroy any copies immediately.